Literature DB >> 15643501

Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.

Kenji Ikuta1, Kazu Takemura, Masaru Kihara, Masuhiro Nishimura, Nobuhiko Ueda, Shinsaku Naito, Eibai Lee, Eiji Shimizu, Aiko Yamauchi.   

Abstract

Non-small cell lung cancer (NSCLC) often shows intrinsic multidrug resistance, which is one of the most serious problems in cisplatin-based adjuvant chemotherapy. Recently, the constitutive activation of signal transducer and activator of transcription (STAT) factors has been found in a variety of human cancers. In the present study, the mRNA expression of STATs in various human NSCLC cell lines was investigated by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) to determine whether STATs can be implicated in cisplatin resistance and apoptosis inducibility. Cisplatin triggered apoptosis in Ma-46 based on biochemical and morphological findings, but not in Ma-31. The mRNA expression of STAT3 was highest in cisplatin-resistant Ma-31 and lowest in cisplatin-sensitive Ma-46. A 6-hour exposure of cancer cells to cisplatin failed to stimulate STAT3 mRNA expression. Therefore, an increased transcriptional level of constitutive STAT3 may be related to the suppressive regulation of the apoptotic pathway in intrinsically chemo-resistant NSCLC cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643501

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

1.  Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer.

Authors:  Jun Okamura; Yiping Huang; David Moon; Mariana Brait; Xiaofei Chang; Myoung Sook Kim
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

2.  Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK.

Authors:  Nathan M Weir; Karuppaiyah Selvendiran; Vijay Kumar Kutala; Liyue Tong; Shilpa Vishwanath; Murugesan Rajaram; Susheela Tridandapani; Shrikant Anant; Periannan Kuppusamy
Journal:  Cancer Biol Ther       Date:  2007-02-05       Impact factor: 4.742

Review 3.  STAT3 as a target for inducing apoptosis in solid and hematological tumors.

Authors:  Khandaker Al Zaid Siddiquee; James Turkson
Journal:  Cell Res       Date:  2008-02       Impact factor: 25.617

Review 4.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

5.  Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp.

Authors:  Xulong Zhang; Weihua Xiao; Lihua Wang; Zhigang Tian; Jian Zhang
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

Review 6.  STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance.

Authors:  Valeria Poli; Annalisa Camporeale
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

7.  STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.

Authors:  Qian Wang; Bing Lu; Yi Zhang; Jing Yu; Jie Guo; Qianchi Zhou; Hong Lv; Yifeng Sun
Journal:  Hum Cell       Date:  2021-08-09       Impact factor: 4.174

8.  The efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis.

Authors:  Ilona Bednarek; Daniel Sypniewski; Natalia Gawlik; Anna Galilejczyk; Karol Goraus
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

9.  PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.

Authors:  Wen-Pin Su; Fong-Yu Cheng; Dar-Bin Shieh; Chen-Sheng Yeh; Wu-Chou Su
Journal:  Int J Nanomedicine       Date:  2012-08-03

10.  Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.

Authors:  Amy L Stark; Ronald J Hause; Lidija K Gorsic; Nirav N Antao; Shan S Wong; Sophie H Chung; Daniel F Gill; Hae K Im; Jamie L Myers; Kevin P White; Richard Baker Jones; M Eileen Dolan
Journal:  PLoS Genet       Date:  2014-04-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.